FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to neurology, psychiatry, pediatrics, and deals with retardation of psychoverbal development in case of neuro-psychic diseases in children. For this purpose L-tryptophan into composition of standard complex treatment of given pathology is included.
EFFECT: invention insures considerable increase of efficiency and stability of treatment results, which allows to reduce hospitalisation terms and financial costs of treatment considerably.
14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF MADOPAR FOR CORRECTION OF COGNITIVE, MOTIVATION, EMOTIONAL DISTURBANCES IN CHILDREN WITH AUTISTIC SPECTRUM DISORDERS | 2008 |
|
RU2403034C2 |
| APPLICATION OF GLIATILIN AND TRANSCRANIAL MICROPOLARISATION IN TREATMENT OF CHILDREN WITH AUTISTIC DISTURBANCES | 2009 |
|
RU2429831C2 |
| DRUG FOR TREATMENT OF PSYCHOVERBAL DEVELOPMENT RETENTION OF VARIOUS ETIOLOGY | 2007 |
|
RU2333755C1 |
| METHOD FOR CORRECTION OF MENTAL DISTURBANCE IN CHILDREN | 2009 |
|
RU2402973C1 |
| METHOD OF EVALUATING LIMITATION OF VITAL ACTIVITY OF CHILDREN WITH PSYCHONEUROLOGICAL PROFILE | 2009 |
|
RU2391899C1 |
| METHOD OF TREATING ENCEPHALOPATHY IN CHILDREN | 2012 |
|
RU2501584C1 |
| AGENT FOR TREATMENT OF LATE DEGENERATIVE DISEASE OF NERVOUS SYSTEM | 0 |
|
SU1819151A3 |
| METHOD FOR TREATING CHILDREN FOR PSYCHICAL DEVELOPMENT DISORDERS | 2004 |
|
RU2248227C1 |
| METHOD FOR TREATING COGNITIVE DISORDERS IN CHILDREN WITH TUBEROUS SCLEROSIS DUE TO CORRECTING MITOCHONDRIAL DYSFUNCTION | 2004 |
|
RU2271201C2 |
| METHOD FOR DIAGNOSING DEVIATIONS IN NEUROPSYCHICAL DEVELOPMENT OF CHILDREN | 1999 |
|
RU2171625C2 |
